Literature DB >> 3016737

Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.

D H Cohn, P H Byers, B Steinmann, R E Gelinas.   

Abstract

We have characterized a mutation in a pro alpha 1(I) procollagen gene (COL1A1) that results in lethal (type II) osteogenesis imperfecta. The mutation is a single base change that results in a cysteine-for-glycine substitution at position 988 of the triple-helical portion of half of the alpha 1(I) chains of type I collagen. The mutation thus disrupts the (Gly-Xaa-Yaa)n pattern necessary for triple-helix formation, where Xaa and Yaa are other amino acids. These experiments establish the minimal mutation in a type I collagen gene capable of producing lethal disease, and the lethality demonstrates a selective mechanism for the stringent maintenance of the collagen gene structure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016737      PMCID: PMC386434          DOI: 10.1073/pnas.83.16.6045

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Multiexon deletion in an osteogenesis imperfecta variant with increased type III collagen mRNA.

Authors:  M L Chu; V Gargiulo; C J Williams; F Ramirez
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

2.  Intron-mediated recombination may cause a deletion in an alpha 1 type I collagen chain in a lethal form of osteogenesis imperfecta.

Authors:  G S Barsh; C L Roush; J Bonadio; P H Byers; R E Gelinas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity.

Authors:  D O Sillence; K K Barlow; A P Garber; J G Hall; D L Rimoin
Journal:  Am J Med Genet       Date:  1984-02

4.  Osteogenesis imperfecta: update and perspective.

Authors:  P H Byers; J F Bonadio; B Steinmann
Journal:  Am J Med Genet       Date:  1984-02

5.  DNA and chromatin structure of the human alpha 1 (I) collagen gene.

Authors:  G S Barsh; C L Roush; R E Gelinas
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

6.  An abnormal collagen alpha chain containing cysteine in autosomal dominant osteogenesis imperfecta.

Authors:  A C Nicholls; F M Pope; D Craig
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14

7.  Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta.

Authors:  W J de Wet; T Pihlajaniemi; J Myers; T E Kelly; D J Prockop
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

8.  Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; T Mascara; D Chan; W G Cole
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

9.  Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta.

Authors:  B Steinmann; V H Rao; A Vogel; P Bruckner; R Gitzelmann; P H Byers
Journal:  J Biol Chem       Date:  1984-09-10       Impact factor: 5.157

10.  Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.

Authors:  J Bonadio; P H Byers
Journal:  Nature       Date:  1985 Jul 25-31       Impact factor: 49.962

View more
  36 in total

1.  The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues.

Authors:  W G Cole; P E Campbell; J G Rogers; J F Bateman
Journal:  J Med Genet       Date:  1990-09       Impact factor: 6.318

2.  Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.

Authors:  T Pihlajaniemi; J McKeon; S Gay; R Gay; W J de Wet; J C Myers; D J Prockop
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

3.  Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybrids.

Authors:  D K Grange; G S Gottesman; M B Lewis; J C Marini
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

Review 4.  Osteogenesis imperfecta: translation of mutation to phenotype.

Authors:  P H Byers; G A Wallis; M C Willing
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

5.  Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation.

Authors:  P J O'Hara; F J Grant; B A Haldeman; C L Gray; M Y Insley; F S Hagen; M J Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.

Authors:  P H Byers; P Tsipouras; J F Bonadio; B J Starman; R C Schwartz
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

7.  The CpG dinucleotide and human genetic disease.

Authors:  D N Cooper; H Youssoufian
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

Review 8.  IFITM5 mutations and osteogenesis imperfecta.

Authors:  Nobutaka Hanagata
Journal:  J Bone Miner Metab       Date:  2015-06-02       Impact factor: 2.626

9.  Tandem duplication within a type II collagen gene (COL2A1) exon in an individual with spondyloepiphyseal dysplasia.

Authors:  G E Tiller; D L Rimoin; L W Murray; D H Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 10.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.